The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C
Mosley, J. W., E. A. Operskalski, L. H. Tobler, W. W. Andrews, B. Phelps, J. Dockter, C. Giachetti, M. P. Busch, f. t. T.-t. V. Study, and R. E. D. S. Groups. 2005. Viral and host factors in early hepatitis C virus infection. Hepatology 42(1):86-92.
Nakashima, A. K., and P. L. Fleming. 2003. HIV/AIDS surveillance in the United States, 1981-2001. Journal of Acquired Immune Deficiency Syndromes 32(Suppl 1):S68-S85.
NASTAD (National Alliance of State and Territorial AIDS Directors). 2009 (unpublished). Viral hepatitis surveillance survey.
NIH (National Institutes of Health). 2002. NIH consensus statement on management of hepatitis C: 2002. NIH Consensus and State-of-the-Science Statements 19(3):1-46.
Onofrey, S., D. Church, D. Heisey-Grove, P. Briggs, T. Bertrand, and A. J. DeMaria. March 10-13, 2008. Utilizing disease intervention specialist for follow-up on hepatitis C in individuals between the ages of 15 and 25 years: A 3-month pilot program. Paper presented at 2008 National STD Prevention Conference, Chicago, IL.
Overhage, J. M., S. Grannis, and C. J. McDonald. 2008. A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions. American Journal of Public Health 98(2):344-350.
Panackal, A. A., M. M’Ikanatha N, F. C. Tsui, J. McMahon, M. M. Wagner, B. W. Dixon, J. Zubieta, M. Phelan, S. Mirza, J. Morgan, D. Jernigan, A. W. Pasculle, J. T. Rankin, Jr., R. A. Hajjeh, and L. H. Harrison. 2002. Automatic electronic laboratory-based reporting of notifiable infectious diseases at a large health system. Emerging Infectious Diseases 8(7):685-691.
Pungpapong, S., W. R. Kim, and J. J. Poterucha. 2007. Natural history of hepatitis B virus infection: An update for clinicians. Mayo Clinic Proceedings 82(8):967-975.
Ruan, Y., G. Qin, L. Yin, K. Chen, H. Z. Qian, C. Hao, S. Liang, J. Zhu, H. Xing, K. Hong, and Y. Shao. 2007. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: A 3-year follow-up study. AIDS 21(Suppl 8): S39-S46.
Thacker, S. B. 2000. Historical development. In Principles and Practice of Public Health Surveillance, edited by S. Teutsch and R. E. Churchill. Oxford, United Kingdom: Oxford University Press.
Thompson, N. D., J. F. Perz, A. C. Moorman, and S. D. Holmberg. 2009. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Annalsof Internal Medicine 150(1):33-39.
van de Laar, T., O. Pybus, S. Bruisten, D. Brown, M. Nelson, S. Bhagani, M. Vogel, A. Baumgarten, M. L. Chaix, M. Fisher, H. Gotz, G. V. Matthews, S. Neifer, P. White, W. Rawlinson, S. Pol, J. Rockstroh, R. Coutinho, G. J. Dore, G. M. Dusheiko, and M. Danta. 2009. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 136(5):1609-1617.
van den Berg, C. H., C. Smit, M. Bakker, R. B. Geskus, B. Berkhout, S. Jurriaans, R. A. Coutinho, K. C. Wolthers, and M. Prins. 2007. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. European Journal ofEpidemiology 22(3):183-193.
Villano, S. A., D. Vlahov, K. E. Nelson, S. Cohn, and D. L. Thomas. 1999. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29(3):908-914.
Vogt, M., T. Lang, G. Frosner, C. Klingler, A. F. Sendl, A. Zeller, B. Wiebecke, B. Langer, H. Meisner, and J. Hess. 1999. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. New England Journal of Medicine 341(12):866-870.